ATE311897T1 - Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone - Google Patents

Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone

Info

Publication number
ATE311897T1
ATE311897T1 AT00915185T AT00915185T ATE311897T1 AT E311897 T1 ATE311897 T1 AT E311897T1 AT 00915185 T AT00915185 T AT 00915185T AT 00915185 T AT00915185 T AT 00915185T AT E311897 T1 ATE311897 T1 AT E311897T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
interferon
treatment
growth hormone
combination
Prior art date
Application number
AT00915185T
Other languages
English (en)
Inventor
Remy Sadoul
Sonia Pagliusi
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE311897T1 publication Critical patent/ATE311897T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00915185T 1999-04-08 2000-03-20 Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone ATE311897T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99106929A EP1043027A1 (de) 1999-04-08 1999-04-08 Behandlung von multiplersklerose mit einer kombination von interferon und Wachstumshormone
PCT/EP2000/002443 WO2000061176A2 (en) 1999-04-08 2000-03-20 Treatment of multiple sclerosis with a combination of interferon and growth hormone

Publications (1)

Publication Number Publication Date
ATE311897T1 true ATE311897T1 (de) 2005-12-15

Family

ID=8237920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915185T ATE311897T1 (de) 1999-04-08 2000-03-20 Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone

Country Status (9)

Country Link
US (1) US6869600B1 (de)
EP (2) EP1043027A1 (de)
JP (1) JP2002541211A (de)
AT (1) ATE311897T1 (de)
AU (1) AU776181B2 (de)
CA (1) CA2365070A1 (de)
DE (1) DE60028559T2 (de)
IL (1) IL145722A0 (de)
WO (1) WO2000061176A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002246619A1 (en) * 2000-12-08 2003-06-23 Neuronz Limited Use of insuline-like growth factor-i for promoting remyelination of axons
US7714020B2 (en) 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
ATE435852T1 (de) 2001-05-24 2009-07-15 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US7605177B2 (en) 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
US20100239528A1 (en) * 2007-07-20 2010-09-23 Stem Cell Therapeutics Corp. Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta
KR20180017232A (ko) * 2008-06-20 2018-02-20 노파르티스 아게 다발성 경화증을 치료하기 위한 소아용 조성물
US8691790B2 (en) * 2009-07-27 2014-04-08 James Layne Boucher Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
EP2670406B1 (de) * 2011-12-21 2015-09-02 InnoBioscience, LLC Kombinationstherapie mit interferon beta und andrographoliden für multiple sklerose
CA2899961C (en) * 2013-02-14 2022-08-09 Cornell University Methods to protect against and treat multiple sclerosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898856A (en) * 1984-10-29 1990-02-06 Chaovanee Aroonsakul Method for treating central nervous system diseases
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
JPH06503320A (ja) * 1990-10-25 1994-04-14 ジェネンテク，インコーポレイテッド 再活性化酸素種に対する防御剤の使用
US5426096A (en) * 1992-03-18 1995-06-20 Soenksen; Peter Use of human growth hormone
US5780021A (en) * 1993-03-05 1998-07-14 Georgetown University Method for treating type 1 diabetes using α-interferon and/or β-i
US6024734A (en) * 1994-03-31 2000-02-15 Brewitt; Barbara A. Treatment methods using homeopathic preparations of growth factors
US6297212B1 (en) * 1994-05-31 2001-10-02 Gregory M. Fahy Growth hormone therapy and related methods and pharmaceutical compositions
US6187750B1 (en) * 1999-08-25 2001-02-13 Everyoung Technologies, Inc. Method of hormone treatment for patients with symptoms consistent with multiple sclerosis

Also Published As

Publication number Publication date
AU776181B2 (en) 2004-09-02
IL145722A0 (en) 2002-07-25
CA2365070A1 (en) 2000-10-19
JP2002541211A (ja) 2002-12-03
EP1043027A1 (de) 2000-10-11
WO2000061176A3 (en) 2001-01-25
AU3658400A (en) 2000-11-14
DE60028559T2 (de) 2006-10-05
EP1165118A2 (de) 2002-01-02
US6869600B1 (en) 2005-03-22
EP1165118B1 (de) 2005-12-07
DE60028559D1 (de) 2006-07-20
WO2000061176A2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
ATE104854T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose.
ES2162393T3 (es) Terapia de combinacion para erradicar el hcv-rna detectable en pacientes con infeccion de hepatitis c cronica.
EP0744409A4 (de) Beschleuniger des plättchenwachstums
LV10054A (lv) Pretvirusu antibakterials savienojums un lietosanas metode
HU9602937D0 (en) Compositions comprising dna damaging agents and p53
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
EE9900428A (et) Köhavastased ravimkoostised
DE60237721D1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
ATE275419T1 (de) Pharmazeutisches kombinationspräparat aus parathormon und einem inhibitor der knochenresorption
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE60028559D1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
DE3777845D1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
CA2097878A1 (en) Therapeutic agent for neutropenia
WO1999013894A3 (en) Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties